image goes here
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
IQVIA and Advarra partnered to advance Operation Warp Speed COVID-19 vaccine trials and deliver exemplary service to sponsors and clinical research sites.
The results:
- IBC approval timelines reduced to under 2 working days
- Participating sites approved 78% faster
- Sites activated to “ready to enroll” 71% faster
- Trial results delivered to sponsor quicker than expected
To learn more, download the case study.
DATE
Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour